Having fatsos pay for their own screening and treatment are the next best things to being cost-effective.
Screening for type 2 diabetes in high-risk patient populations likely saves money even in the short term, researchers affirmed here.Any other approach is only income effective for the deliverers of sick care.
For middle-age or older adults and for the obese, every screening method evaluated was projected to reduce costs to the healthcare system over a three year span even when factoring in medication costs and false negatives, found Ranee Chatterjee, MD, of Johns Hopkins, and colleagues.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.